China BCT Pharmacy Group, Inc. (CNBI) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate China BCT Pharmacy Group, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
0.48
Strong
WeakModerateStrong
P/B Ratio
0.06
Strong
WeakModerateStrong
Earnings Yield
2.76%
Yield Trap
WeakModerateStrong
Profitability Health
2012Return on Equity
15.68%
Strong
WeakModerateStrong
Operating Margin
12.15%
Moderate
WeakModerateStrong
Net Profit Margin
8.70%
Moderate
WeakModerateStrong
Growth Indicators
2012Revenue Growth
-6.07%
Weak
WeakModerateStrong
Net Income Growth
-32.51%
Weak
WeakModerateStrong
EPS Growth
-41.67%
Weak
WeakModerateStrong
Efficiency & Liquidity
2012Current Ratio
2.72
Strong
WeakModerateStrong
Quick Ratio
2.53
Strong
WeakModerateStrong
Asset Turnover
0.99x
Moderate
WeakModerateStrong
Inventory Turnover
14.20x
Strong
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-2.01%
Weak
WeakModerateStrong
EV / Free Cash Flow
-0.15x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.17x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.971
Strong
WeakModerateStrong
Return on Invested Capital
11.56%
Weak
WeakModerateStrong
Cash Conversion Cycle
183.46 days
Weak
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for CNBI.
View Financial Statements